GG 931 (Orphenadrine Citrate Extended-Release 100 mg)

Pill imprint GG 931 has been identified as Orphenadrine citrate extended-release 100 mg.

Orphenadrine is used in the treatment of muscle spasm; migraine and belongs to the drug class skeletal muscle relaxants. Risk cannot be ruled out during pregnancy. Orphenadrine 100 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for GG 931

Orphenadrine citrate extended-release 100 mg GG 931
Orphenadrine citrate extended-release
Imprint:
GG 931
Strength:
100 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Skeletal muscle relaxants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Actavis
National Drug Code (NDC):
52152-0340
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
43386-0480 Gavis Pharmaceuticals
55045-1325 Dispensing Solutions Inc. (repackager)
57866-7601 Direct Dispensing Inc (repackager)
10544-0359 Blenheim Pharmacal Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)